top of page

Blood test identified as a good biomarker for idiopathic PAH

A relatively simple, inexpensive, and minimally invasive test for idiopathic pulmonary arterial hypertension (IPAH) would aid in the diagnosis of this disease. This study found that levels of the NOTCH3 extracellular domain (NOTCH3-ECD) shed into blood serum could be used as a biomarker for IPAH. They found that NOTCH3-ECD levels did correlate with the presence and severity of IPAH.


 
 
 

Recent Posts

AI May Help Predict PAH Patients' Risk of Worsening

Researchers looked at the medical records of 455 people with pulmonary arterial hypertension (PAH) to find factors associated with getting worse. Using a machine-learning computer model, they found 11

 
 
 
Sotatercept and cardiopulmonary comorbidities

This study from one clinic examined how well sotatercept worked in real-world patients with pulmonary arterial hypertension (PAH) who also had other heart or lung conditions, such as coronary artery d

 
 
 

2 Comments


vbb64316
May 20

The detection of a biomarker for IPAH wacky flip through blood testing is a very positive sign, as early diagnosis always plays a crucial role in treatment and improving the quality of life for patients.

Like

That’s really encouraging-having a simple sprunki game blood test that can reflect both presence and severity could make a big difference for earlier diagnosis and monitoring.

Like

PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

Charitable Registration # 872050224RR0001

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe

bottom of page